ClinicalTrials.gg
RecruitingNCT07889765CDOTrainUpdated Oct 22, 2026

Comparative Effect of Training Methods to Reduce Forefoot Loading in Carbon Fiber Custom Dynamic Orthoses

An interventional study of Carbon Fiber Custom Dynamic Orthosis in Healthy, sponsored by Jason Wilken. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Jason Wilken · Not applicable, Interventional, and Other

How we know

Updated Oct 22, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Carbon fiber custom dynamic orthoses (CDOs) include a full-length footplate, a stiff posterior spring, and a cuff that wraps around the leg below the knee. CDOs restore function after limb trauma, decrease forefoot loading, and reduce pain. However, initial introduction to a CDO is not consistent, so this study is being conducted to determine if different methods of training alter forefoot loading during gait. Unimpaired adult participants will be randomized to one of three groups: 1) no feedback, 2) visual feedback of forefoot force, and 3) visual feedback of cuff forces. All participants will walk at a controlled speed on a treadmill without the CDO, after initial introduction to the CDO, and after completing two rounds of training in the CDO.

Read the detailed description

Carbon fiber custom dynamic orthoses (CDOs) restore function for individuals with limb trauma. CDOs include a full-length footplate, a stiff posterior spring, and a proximal cuff that wraps around the leg below the knee. A key benefit of CDOs is the ability to decrease forefoot loading, which may reduce pain during walking. However, initial introduction to a CDO is not consistent and some individuals struggle to relax their lower leg muscles and rely on the CDO for support, reducing the potential offloading benefits of the CDO and increasing the risk of abandoning the CDO.

In this study we will investigate different methods of training, with or without visual feedback, to determine if training method alters forefoot loading during walking. Unimpaired adult participants will be randomized to one of three groups: 1) no feedback, 2) visual feedback of forefoot force, and 3) visual feedback of cuff forces. All participants will walk at a controlled speed on a treadmill without the CDO, after initial introduction to the CDO, and after completing two rounds of training in the CDO. Participants will complete questionnaires regarding pain and perceived CDO comfort and smoothness. Force within the CDO cuff and footplate will be measured using wireless force measuring sensors (Loadsol/Loadpad, Novel Electronics).

02

Conditions studied

  • Healthy

Keywords

  • Carbon Fiber
  • Ankle Foot Orthosis
  • Foot Loading
03

In context

Lead sponsor

Jason Wilken is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Ages 18-65.
  2. Without current complaint of lower extremity pain, spine pain, open wounds or active infection.
  3. Ability to hop without pain.
  4. Ability to perform a full squat without pain.
  5. Ability to read and write in English and provide written .

Exclusion criteria

Exclusion Criteria:

  1. Diagnosis with a moderate or severe brain injury.
  2. Diagnosis with a physical or psychological condition that would preclude functional testing (e.g. cardiac condition, clotting disorder, pulmonary condition).
  3. Medical conditions or injuries that have limited participation in work or exercise in the last 6 months.
  4. Medical conditions of injuries limiting function for greater than 6 weeks.
  5. Uncorrected visual or hearing impairments.
  6. Use of an assistive device.
  7. Wounds preventing CDO use
  8. Pregnancy
  9. greater than 35 kg/m2.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
51 participants (estimated)

Study arms

  • Experimental
    No Visual Feedback

    Participants will walk in the study CDO without visual feedback of limb loading during gait.

    Device: Carbon Fiber Custom Dynamic Orthosis

  • Experimental
    Visual Feedback of Forefoot Force

    Participants will walk in the study CDO while being provided visual feedback of forefoot loading loading during gait. Forefoot loading will be measured using wireless insoles placed in the CDO footplate.

    Device: Carbon Fiber Custom Dynamic Orthosis

  • Experimental
    Visual Feedback of Cuff Force

    Participants will walk in the study CDO while being provided visual feedback of cuff loading loading during gait. Cuff loading will be measured using wireless insoles placed in the CDO proximal cuff.

    Device: Carbon Fiber Custom Dynamic Orthosis

  • No intervention
    NoCDO

    Participants will walk without a CDO.

Interventions

  • DeviceCarbon Fiber Custom Dynamic Orthosis

    The carbon fiber custom dynamic orthosis (CDO) used in this study will consist of a semi-rigid carbon fiber footplate, a carbon fiber posterior strut, and a proximal cuff that wraps around the leg below the knee.

    Also known as: Ankle Foot Orthosis

06

What researchers measure

Primary outcomes

  1. Peak Forefoot Force

    Peak plantar forces, normalized to body mass (N/kg) will be measured across the forefoot (distal 40% of sensor).

    Time frame: Baseline

  2. Forefoot Force Impulse

    Plantar force impulse, normalized to body mass (Ns/kg) across the forefoot (distal 40% of sensor) will be calculated using the integral of the force over the stance phase.

    Time frame: Baseline

Secondary outcomes

  1. Peak Midfoot Force

    Peak plantar forces, normalized to body mass (N/kg) will be measured across the midfoot (middle 30% of sensor).

    Time frame: Baseline

  2. Midfoot Force Impulse

    Plantar force impulse, normalized to body mass (Ns/kg) across the midfoot (middle 30% of sensor) will be calculated using the integral of the force over the stance phase.

    Time frame: Baseline

  3. Peak Hindfoot Force

    Peak plantar forces, normalized to body mass (N/kg) will be measured across the hindfoot (proximal 30% of sensor).

    Time frame: Baseline

  4. Hindfoot Force Impulse

    Plantar force impulse, normalized to body mass (Ns/kg) across the hindfoot (proximal 30% of sensor) will be calculated using the integral of the force over the stance phase.

    Time frame: Baseline

  5. Peak Total Foot Force

    Peak plantar forces, normalized to body mass (N/kg) will be measured across the total foot (100% of sensor).

    Time frame: Baseline

  6. Total Foot Force Impulse

    Plantar force impulse, normalized to body mass (Ns/kg) across the total foot (100% of sensor) will be calculated using the integral of the force over the stance phase.

    Time frame: Baseline

Other outcomes

  1. Numerical Pain Rating Scale

    Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable

    Time frame: Baseline

  2. Modified Socket Comfort Score (Comfort)

    Comfort scores range from 0 = most uncomfortable to 10= most comfortable

    Time frame: Baseline

  3. Modified Socket Comfort Score (Smoothness)

    Smoothness scores range from 0 = least smooth to 10 = most smooth

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2026
First posted
Oct 22, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Jun 1, 2027
CompletionEst.
Jun 1, 2027
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889765
Lead sponsor
Jason Wilken
Responsible party
Jason Wilken (Associate Professor, University of Iowa) — Sponsor-investigator
First posted
Oct 22, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Jason M Wilken, PT, PhD
Contact
jason-wilken@uiowa.edu
319-335-6857
Kirsten M Anderson, PhD
Contact
kirsten-m-anderson@uiowa.edu
319-353-0431

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion